OncoSil Medical Ltd. announced that it has received notice from Non-Executive Director, Mr. Brian Leedman, that in accordance with clause 13.2 of the Company's constitution regarding the rotation of Directors at each Annual General Meeting (AGM), that he will be retiring from the Company at this year's AGM and will not be standing for re-election.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | 0.00% | -44.44% |
Jun. 03 | Oncosil Medical Treats 200th Pancreatic Cancer Patient with Proprietary Device | MT |
May. 23 | Oncosil Medical Enters Distribution Agreement with Abdulla Fouad Group for Saudi Arabia | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.44% | 11.13M | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- OSL Stock
- News OncoSil Medical Limited
- OncoSil Medical Limited Announces Retirement of Brian Leedman from the Board